CYSTUS052

10/01/2007 - "Thus, a local application of CYSTUS052 at the viral entry routes may be a promising approach that may help to protect from influenza virus infections."
12/01/2009 - "In this prospective, randomized, placebo-controlled clinical study we aimed to investigate the clinical effect of a Cistus extract (CYSTUS052) in 160 patients with infections of the upper respiratory tract. "
12/01/2009 - "Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract. "
01/01/2010 - "The present work aimed to investigate the clinical effect of a Cistus extract (CYSTUS052) in comparison with green tea on 300 patients with infections of the upper respiratory tract. "
01/01/2010 - "Effect of CYSTUS052 and green tea on subjective symptoms in patients with infection of the upper respiratory tract."

01/01/2010 - "Due to the lack of clinical study data on their efficacy in patients, this is a report of the findings of our study on the clinical efficacy of CYSTUS052 in patients with the upper respiratory tract infections (URTIs). "
01/01/2010 - "CYSTUS052 therefore proved to be an effective adjuvant for the treatment of respiratory infections."

10/01/2007 - "Here we demonstrate that a polyphenol rich extract (CYSTUS052) from the Mediterranean plant Cistus incanus exerts a potent anti-influenza virus activity in A549 or MDCK cell cultures infected with prototype avian and human influenza strains of different subtypes. "

10/01/2007 - "Here we show that CYSTUS052, a plant extract from a special variety of Cistus incanus that is rich in polymeric polyphenols, exhibits antiviral activity against a highly pathogenic avian influenza A virus (H7N7) in cell culture and in a mouse infection model. "

12/01/2009 - "The present randomised, placebo-controlled clinical study was designed to compare the symptom scores in patients with common cold treated either with CYSTUS052 or with placebo. "